| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/10/2002 | CN1358194A Streptogramin derivatives, preparation and compositions containing them |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1087349C novel process for preparing N-acetyl(L)-4-cyanophenylamine Ac-(L)-phe(4-CN)-OH and N-acetyl-(L)-P-amidinophenylalantne-cyclohexylglycine-beta-(3-N-methylpyridinium)alanine Ac-(L)-pAph-Chg-palme(3)-NH2 |
| 07/10/2002 | CN1087283C New LH-RH antigonists with improved effectiveness |
| 07/09/2002 | US6417397 Drug delivery, bioavailability; prodrugs |
| 07/09/2002 | US6417387 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 07/09/2002 | US6417161 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| 07/09/2002 | US6417010 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
| 07/09/2002 | US6416949 Composition comprising first solid support linked to peptide covalently attached via linking group to second solid support linked to oligonucleotide, wherein supports are beads covalently attached by heterobifunctional crosslinking agent |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/04/2002 | WO2002051862A2 Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units |
| 07/04/2002 | WO2002051846A1 Apicidin-derivatives, their synthetic methods, and antitumor compositions containing the same |
| 07/04/2002 | US20020087007 Process for preparing pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid |
| 07/04/2002 | US20020086872 Anticoagulants; may be embedded in or physically linked to materials used in manufacture of devices used in blood collection, circulation, stents |
| 07/04/2002 | US20020086828 Uses for amino acid anticonvulsants |
| 07/04/2002 | US20020086815 Cancer therapy; for skin cancer, myeloids |
| 07/03/2002 | EP1219659A1 Amphipathic compound having dendritic structure |
| 07/03/2002 | EP1219634A1 Cytostatic-glycoconjugates having specifically cleavable peptidic linking units |
| 07/03/2002 | EP1219633A1 Process for producing aspartame derivative, crystals thereof, novel production intermediates therefor and process for producing the intermediate |
| 07/03/2002 | EP1218544A1 Methods for identifying rna binding compounds |
| 07/03/2002 | EP1218496A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 07/03/2002 | EP1218403A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 07/03/2002 | EP0938326A4 Synthetic phosphopeptides for treating bone diseases |
| 07/03/2002 | CN1356913A Vitronectic receptor antagonist pharmaceuticals |
| 07/03/2002 | CN1356338A Separation, synthesis and application in medicine for P6A'S metabolic product |
| 07/02/2002 | US6414114 Useful as agents in oxidation-reduction equilibrium in cells; enzyme regulation in homeostasis |
| 07/02/2002 | US6414112 Peptide nucleic acids having 2,6-diaminopurine nucleobases |
| 07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
| 07/02/2002 | US6413530 Pesticidal peptides |
| 07/02/2002 | CA2167678C Radioactive peptides |
| 06/27/2002 | WO2002050101A1 Retinoblastoma-binding protein |
| 06/27/2002 | WO2002050100A2 Diaminodicarboxylic acid: peptide-based gemini surfactant compounds used for drug delivery |
| 06/27/2002 | WO2002050084A2 Streptogramin derivatives preparation thereof and compositions containing same |
| 06/27/2002 | WO2002050056A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/27/2002 | WO2002050051A1 Chemical compounds |
| 06/27/2002 | WO2002050019A2 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | WO2002049577A2 Analogues of thiocoraline and be-22179 |
| 06/27/2002 | WO2002028809A3 Dynamic resolution of isomers and resolved isomers |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2001096286A3 Urokinase inhibitors |
| 06/27/2002 | WO2001094381A3 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 06/27/2002 | WO2001081426A3 Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 06/27/2002 | US20020081310 Apoptosis-related compounds and their use |
| 06/27/2002 | CA2432908A1 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | CA2431588A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/27/2002 | CA2430782A1 Analogues of thiocoraline and be-22179 |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/26/2002 | CN1355810A Prodrugs of thrombin inhibitors |
| 06/26/2002 | CN1355173A Liquid-phase synthesis process of octreotide acetate |
| 06/25/2002 | US6410684 Serine protease inhibitors |
| 06/25/2002 | US6410585 Therapy for non-insulin depend diabetes |
| 06/25/2002 | US6410576 Antiinflammatory agents; cardiovascular disorders |
| 06/25/2002 | US6410548 Spiropiperidine derivatives as melanocortin receptor agonists |
| 06/25/2002 | US6410531 For therapy of hepatitis c virus (hcv) infection |
| 06/25/2002 | US6410515 Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| 06/20/2002 | WO2002048180A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 06/20/2002 | WO2002048172A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/20/2002 | WO2002048157A2 Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors |
| 06/20/2002 | WO2002048116A2 Inhibitors of hepatitis c virus ns3 protease |
| 06/20/2002 | WO2002047671A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 06/20/2002 | WO2002022571A3 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 06/20/2002 | WO2002006190A3 Crystalline and salt forms of an hiv protease inhibitor |
| 06/20/2002 | WO2001090194A3 Antibodies against particular forms of propsa and use thereof in immunoassays |
| 06/20/2002 | WO2001083559A3 Production and use of protein variants having modified immunogenecity |
| 06/20/2002 | WO2001083436A3 Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 06/20/2002 | WO2001077113A3 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 06/20/2002 | US20020077338 HIV protease inhibitors |
| 06/20/2002 | US20020077290 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 06/20/2002 | CA2430972A1 Fibrin fragments for treating inflammation |
| 06/20/2002 | CA2430458A1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/19/2002 | EP1215215A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
| 06/19/2002 | EP1215213A2 Bicyclic amino-pyrazone derivatives, their preparation and pharmaceutical compositions containing them |
| 06/19/2002 | EP1215207A2 Salts of isoleucyl-thiazolidine and -pyrrolidine and their use as dipeptidylpeptidase inhibitors |
| 06/19/2002 | EP1214936A2 Use of thiazolidin- or pyrrolidin-derivatives of aminoacids as antihyperglycemic agents |
| 06/19/2002 | EP1214336A1 Synthesis of template-fixed beta-hairpin loop mimetics |
| 06/18/2002 | US6407134 Viricide for human t-cell leukemia/lymphoma virus |
| 06/18/2002 | US6407080 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 06/18/2002 | US6407067 Salts of thrombin inhibitors |
| 06/18/2002 | US6407066 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/18/2002 | CA2241725C Growth-hormone secretagogues |
| 06/18/2002 | CA2057786C Amino and nitro containing tricyclic compounds useful as inhibitors or ace |
| 06/13/2002 | WO2002046147A2 Perturbed membrane-binding compounds |
| 06/13/2002 | WO2002045524A2 Prolyl endoprotease from aspergillus niger |
| 06/13/2002 | WO2002045523A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 06/13/2002 | WO2001074844A3 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 06/13/2002 | US20020072586 Chiral peptide nucleic acids |
| 06/13/2002 | CA2436601A1 Perturbed membrane-binding compounds |
| 06/13/2002 | CA2430893A1 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 06/12/2002 | EP1213284A1 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 06/12/2002 | EP1212363A2 Il-16 antagonists |
| 06/12/2002 | EP1212350A1 A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh 2? |
| 06/12/2002 | EP1212300A1 Azacycloalkanone serine protease inhibitors |
| 06/12/2002 | EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 06/12/2002 | EP1212098A2 Enzyme inhibitors |
| 06/12/2002 | EP1056722B1 Bisulfate salt of hiv protease inhibitor |
| 06/12/2002 | EP0734391B1 Pna-dna-pna chimeric macromolecules |
| 06/12/2002 | CN1353757A Microbiological production method for 2-L-aspartyl-L-phenylalanine |
| 06/12/2002 | CN1353701A Peptidyl heterocyclic ketones useful as tryptase inhibitors |
| 06/11/2002 | US6403763 Chiral peptide nucleic acids which hybridize strongly with complementary nucleic acids; antigene and antisense agents; tools in molecular biology |
| 06/11/2002 | US6403585 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |